checkAd

     180  0 Kommentare Study Utilizing Imaging Mass Cytometry Details Changes in Lung Tissue Architecture at the Single-Cell Level in Patients with COVID-19 - Seite 4

    Available Information
    We use our website (fluidigm.com), investor site (investors.fluidigm.com), corporate Twitter account (@fluidigm), Facebook page (facebook.com/Fluidigm), and LinkedIn page (linkedin.com/company/fluidigm-corporation) as channels of distribution of information about our products, our planned financial and other announcements, our attendance at upcoming investor and industry conferences, and other matters. Such information may be deemed material information, and we may use these channels to comply with our disclosure obligations under Regulation FD. Therefore, investors should monitor our website and our social media accounts in addition to following our press releases, SEC filings, public conference calls, and webcasts.

    Contacts:

    Media:
    Mark Spearman
    Senior Director, Corporate Communications
    650 243 6621
    mark.spearman@fluidigm.com

    Investors:
    Agnes Lee
    Vice President, Investor Relations
    650 416 7423
    agnes.lee@fluidigm.com

    Lesen Sie auch

     


    Seite 4 von 4




    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Study Utilizing Imaging Mass Cytometry Details Changes in Lung Tissue Architecture at the Single-Cell Level in Patients with COVID-19 - Seite 4 Weill Cornell Medicine Researchers Utilize Fluidigm Hyperion Imaging System to Identify a Phenotype of Immune Cell Activity Distinct from Other Lung Infections A Framework for Data-Driven Spatial Understanding of Lung Pathology to Inform New …